Supreme Court gives pharma giants another chance to sidestep terrorism-funding case

The U.S. Court of Appeals for the District of Columbia must reevaluate whether the plaintiffs can go forward with their claims in the case involving 21 pharmaceutical and medical device companies, including AstraZeneca, GE Healthcare Technologies, Johnson & Johnson, Pfizer and Roche.